【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by MOA
07.1.1 Anticholinergics
07.1.2 Beta-Adrenergic Antagonists
07.1.3 COMT Inhibitors
07.1.4 Dopamine Agonists
07.1.5 Dopamine Replenishers
07.1.6 MAOB Inhibitors
07.1.7 Others
08. Geographical Segmentation
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Market Share Analysis 2013
16.2.1 Novartis
16.2.2 Boehringer
16.2.3 Teva
16.2.4 GlaxoSmithKline
17. Key Late-Stage Pipeline Candidates
17.1 Key Information for Late-Stage Pipeline Candidates
17.1.1 ABT-SLV187
17.1.2 BIA 9-1067
17.1.3 IPX066
17.1.4 KW-6002
17.1.5 NW 1015
17.1.6 OS-320
17.1.7 P2B 001
17.2 Key Late-Stage Discontinued Drug Candidates
18. Other Prominent Vendors
19. Key Vendor Analysis
19.1 Boehringer Ingelheim
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation
19.1.4 Business Strategy
19.1.5 Revenue Segmentation by Business /Products
19.1.6 Sales by Geographical Segmentation
19.1.7 Key Information
19.1.8 SWOT Analysis
19.1.9 Strengths
19.1.10 Weaknesses
19.1.11 Opportunities
19.1.12 Threats
19.2 GlaxoSmithKline
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation
19.2.4 Business Segmentation by Revenue 2012 and 2013
19.2.5 Sales by Geography
19.2.6 Pipeline Products
19.2.7 Business Strategy
19.2.8 Key Information
19.2.9 SWOT Analysis
19.2.10 Strengths
19.2.11 Weaknesses
19.2.12 Opportunities
19.2.13 Threats
19.3 Novartis
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue 2013
19.3.4 Business Segmentation by Revenue 2012 and 2013
19.3.5 Sales by Geography
19.3.6 Business Strategy
19.3.7 Key Developments
19.3.8 SWOT Analysis
19.3.9 Strengths
19.3.10 Weaknesses
19.3.11 Opportunities
19.3.12 Threats
19.4 Teva
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation
19.4.4 Business Segmentation by Revenue 2013
19.4.5 Business Segmentation by Revenue 2012 and 2013
19.4.6 Sales by Geography
19.4.7 Business Strategy
19.4.8 Key Developments
19.4.9 SWOT Analysis
19.4.10 Strengths
19.4.11 Weakness
19.4.12 Opportunities
19.4.13 Threats
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Parkinson’s Disease Market 2013-2018 (US$ billion)
Exhibit 3: Global Parkinson’s Disease Market Segmentation by MOA
Exhibit 4: Anticholinergics Approved for the Treatment of Parkinson’s Disease
Exhibit 5: Beta-Adrenergic Antagonists Approved for the Treatment of Parkinson’s Disease
Exhibit 6: COMT Inhibitors Approved for the Treatment of Parkinson’s Disease
Exhibit 7: Dopamine Agonists Approved for the Treatment of Parkinson’s Disease
Exhibit 8: Dopamine Replenishers Approved for the Treatment of Parkinson’s Disease
Exhibit 9: MAOB Inhibitors Approved for the Treatment of Parkinson’s Disease
Exhibit 10: Some Other Drugs Approved for the Treatment of Parkinson’s Disease
Exhibit 11: Global Parkinson’s Disease Market by Geographical Segmentation 2013
Exhibit 12: Geography-wise Segmentation of Novartis’ Comtan and Stalevo Sales 2013
Exhibit 13: Geography-wise Segmentation of Exelon’s Sales in 2013
Exhibit 14: Geography-wise Revenue of Requip in 2013 (US$ million)
Exhibit 15: Business Segmentation of Boehringer Ingelheim Gmbh
Exhibit 16: Net Sales by Business of Boehringer Ingelheim GmbH
Exhibit 17: Revenue Segmentation by Business /Products (2013)
Exhibit 18: Sales by Geographical Segmentation (2013)
Exhibit 19: GlaxoSmithKline Plc: Business Segmentation 2013
Exhibit 20: GlaxoSmithKline Plc: Business Segmentation by Revenue 2012 and 2013 (in US$ billion)
Exhibit 21: GlaxoSmithKline Plc: Sales by Geography 2013
Exhibit 22: GlaxoSmithKline plc: Pipeline Products 2013
Exhibit 23: Novartis AG: Business Segmentation by Revenue 2013
Exhibit 24: Novartis AG: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 25: Novartis AG: Sales by Geography 2013
Exhibit 26: Teva Pharmaceutical Industries Ltd.: Business Segmentation
Exhibit 27: Teva Pharmaceutical Industries Ltd.: Business Segmentation by Revenue 2013
Exhibit 28: Teva Pharmaceutical Industries Ltd.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 29: Teva Pharmaceutical Industries Ltd.: Sales by Geography 2013
【レポート販売概要】
■ タイトル：世界のパーキンソン病治療市場（2014-2018）■ 英文：Global Parkinson's Disease Market 2014-2018
■ 発行日：2014年7月23日
■ 調査会社：Technavio
■ 商品コード：IRTNTR3862
■ 調査対象地域：グローバル
- Gleevec (Chronic Myeloid Leukemia)：市場予測と分析（～2022）Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL fusion protein. The stage of CML is classified …
- 業務用コーヒーメーカーの世界市場2016-2020About Commercial Coffee Brewers Globally, the commercial coffee brewer market is driven by numerous factors such as increasing consumer preference for fresh brewed coffee, food service establishments' need to offer coffee with a better and consistent taste, and influx of new models of commercial coffee brewers with better controls and features. In addition, globally, many coffee providers are also …
- デジタルマップ（電子地図）の世界市場2015-2019About digital maps Digital mapping is a process by which data is collected and compiled to form a virtual image. The data compiled is used to produce maps that accurately represent a particular geographical area or feature, including major roads, rivers, and important landmarks such as airports, tourist attractions, and hospitals. Digital mapping technology also provides an option to calculate the …
- 世界の地熱ポンプ（GHP）システム市場（2014-2018）TechNavio's analysts forecast the Global Geothermal Heat Pump (GHP) System market to grow at a CAGR of 15.50 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to reduce the dependence on fossil-fuels. The Global GHP System market has also been witnessing the increase in technological advancement. However, the need for high levels of initial in …
- 食肉加工機械のグローバル市場（2014-2018）About Meat Processing Equipment Meat processing equipment is generally used in the transformation of raw ingredients into ready-to-eat meat or into other forms. Meat processing involves the use of a variety of applications on raw meat to convert it to the required form. . This equipment facilitates toxin removal, preservation, eases marketing and distribution tasks, and also increases meat consist …
- 世界の量子ドット市場動向（2012-2016）TechNavio's analysts forecast the Global Quantum Dots market to grow at a CAGR of 54.29 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing number of quantum dots-based products. The Global Quantum Dots market has also been witnessing the increasing adoption of quantum dots by life sciences and biomedical communities. However, the high cos …
- 世界のVoice over Mobile Broadband (VoMBB)市場動向（2012-2016）Global Voice over Mobile Broadband (VoMBB) Market 2012-2016 Voice over Mobile Broadband, or VoMBB, has been recently gaining traction in the Global Telecom industry and is unanimously expected to generate huge revenue for telecom network operators in the coming years. Conceptually, VoMBB is about encompassing carrier-grade voice calls over LTE, Wi-Fi and HSPA/HSPA+ networks. While Wi-Fi is a nifty …
- 無人地上車両（UGV）の世界市場予測（～2021年）“Demand for increased efficiency in commercial and defense operations is the key factor influencing the growth of the unmanned ground vehicle market”The unmanned ground vehicle market is estimated to be valued at USD 1.49 billion in 2016 and is projected to reach USD 2.63 billion by 2021, at a CAGR of 12.14% during the forecast period. The increasing demand for enhanced efficiency, human safety, a …
- BRIC地域における人工心臓弁の市場動向（～2020）BRIC Prosthetic Heart Valves Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Prosthetic Heart Valves Market Outlook to 2020", provides key market data on the BRIC Prosthetic Heart Valves market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Mechanical Heart Valves, Tissue Heart Valves and …
- 世界のタブレットPC用OS市場動向（2012-2016）TechNavio's analysts forecast the Global Tablet Operating System (OS) market to grow at a CAGR of 35.2 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing sale of tablets. The Global Tablet OS market has also been witnessing timely upgrades of OS. However, high production costs could pose a challenge to the growth of this market. TechNavio …
- ベビーフード（乳児食）の世界市場動向2014Summary “Baby Nutrition Insights 2014 - Issue 21” is a new report that is the result of ERC's extensive market research covering the baby food industry. It is a quarterly review of the latest news and analysis for the infant formula and baby food industry. The report covers all the major countries across all geographies and provides latest updates for companies engaged in the baby food market. Key …
- 航空サイバーセキュリティの世界市場：航空機、空港、CRS/GDS、航空交通管理システムOver the course of the last decade, and especially in the last few years, cyber security has become an area of mainstream interest, with media reporting on the subject having been intensive. The preceding few years have witnessed an extensive array of government cyber security policy documents, expert conferences, and the full-scale reorganisation of national agencies to counter the unique threats …
- ヒト胚性幹細胞（hESC）の世界市場分析：用途別（再生医療、幹細胞生物学研究、組織工学、毒物学検査）、国別（アメリカ、イギリス、ドイツ、日本、中国）、セグメント予測、2014-2025The global human embryonic stem cells (hESCs) market is anticipated to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility be …
- アメリカの バージ輸送市場2017-2021About Barge Transportation The inland waterway transportation system in the US is one of the world’s most efficient transportation systems with a network of interconnected rivers and canals. Over 1 billion short tons of cargo are moved annually, which makes it a vital part of the US cargo transportation system. Barge transportation is the most efficient and safest means of transporting bulk commod …
- Bone Metastasis：グローバル臨床試験レビューH1, 2013Bone Metastasis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, H1, 2013" provides data on the Bone Metastasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Metastasis. It includes an overview of the trial numbers and their recruitment status as …
